Viridian Therapeutics, Inc. (VRDN)
29.25
+0.08
(+0.27%)
USD |
NASDAQ |
Feb 06, 16:00
29.23
-0.02
(-0.07%)
After-Hours: 20:00
Viridian Therapeutics Market Cap : 2.792B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 27.51M |
| ADMA Biologics, Inc. | 3.910B |
| Avantor, Inc. | 7.677B |
| Immunovant, Inc. | 4.741B |
| Plus Therapeutics, Inc. | 35.72M |
Market Cap Related Metrics
| PS Ratio | 33.55 |
| Price to Book Value | 8.888 |
| Price | 29.25 |
| Earnings Yield | -12.08% |